- Home
- SHAZ vs ATTO Comparison
SHAZ vs ATTO Comparison
Compare SHAZ & ATTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SHAZ | ATTO |
|---|---|---|
| Founded | 2024 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2025 | 2026 |
Fundamental Metrics
Financial Performance| Metric | SHAZ | ATTO |
|---|---|---|
| Price | $22.92 | $13.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $105.00 | $42.20 |
| AVG Volume (30 Days) | ★ 1.8M | 401.1K |
| Earning Date | 11-15-2026 | 09-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,566,631.00 | N/A |
| Revenue This Year | $7,470.09 | N/A |
| Revenue Next Year | $1,195.12 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 257.44 | N/A |
| 52 Week Low | $16.55 | $12.94 |
| 52 Week High | $97.48 | $28.00 |
Technical Indicators
Market Signals| Indicator | SHAZ | ATTO |
|---|---|---|
| Relative Strength Index (RSI) | 20.60 | 30.07 |
| Support Level | $21.17 | $12.94 |
| Resistance Level | $27.01 | $15.54 |
| Average True Range (ATR) | 3.04 | 1.24 |
| MACD | -1.17 | -0.05 |
| Stochastic Oscillator | 2.17 | 13.25 |
Price Performance
Historical ComparisonAbout SHAZ SharonAI Holdings Inc. Class A Common Stock
SharonAI Holdings Inc is a neocloud operator, purpose-built to power the next generation of artificial intelligence (AI) and high-performance computing (HPC). The Company's infrastructure is architected from the ground up to meet the specific, intensive, and complex demands of modern AI training and inference workloads, machine learning, and Generative AI. Its services include: Sovereign AI Australia, GPU-as-a-Service, SHARON AI Cloud, SHARON AI Private Cloud, Virtual Private Clusters, HPC Servers, and SHARON AI Studio. The company's products are: SHARON AI Supercluster, GPU Fleet, Virtual Servers, Cloud Storage, and Machine Learning & Infrastructure. The Company operates in one operating segment, High Performance Compute Services (HPC).
About ATTO Attovia Therapeutics Inc. Common Stock
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.